Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

Question 2

How does BCD-100 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of BCD-100?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any risk of complications from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) clinical trial (NCT03288870). Contact the study team or your healthcare provider for specific answers.

What this study is about